Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of l‐DOPA in Hemiparkinsonian Rats
@article{Finberg1995InfluenceOS, title={Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of l‐DOPA in Hemiparkinsonian Rats}, author={John P.M. Finberg and J. Wang and David S. Goldstein and Irwin J. Kopin and K. S. Bankiewicz}, journal={Journal of Neurochemistry}, year={1995}, volume={65} }
Abstract: The effect of selective inhibition of monoamine oxidase (MAO) subtypes A and B on striatal metabolism of DOPA to dopamine (DA), 3,4‐dihydroxyphenylacetic acid (DOPAC), and 4‐hydroxy‐3‐methoxyphenylacetic acid (homovanillic acid; HVA) was studied in halothane‐anesthetized rats 3 weeks after unilateral 6‐hydroxydopamine lesion of the substantia nigra. Implantation of bilateral microdialysis probes allowed simultaneous quantitation of metabolite production on lesioned and control sides…
54 Citations
Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo
- Biology, ChemistryJournal of neurochemistry
- 1996
DA metabolism was reduced only by clorgyline, whereas neuronal release of DA was enhanced by both MAO‐A andMAO‐B inhibitors on chronic administration, and the enhanced DA release does not appear to be dependent on production of amphetamine‐like metabolites of the inhibitor.
Increased L‐DOPA‐derived dopamine following selective MAO‐A or ‐B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation
- Biology, ChemistryBritish journal of pharmacology
- 2013
This work sought to clarify the roles of MAO‐A andMAO‐B in deamination of DA formed from exogenous L‐DOPA in rat striatum depleted of dopaminergic, or both dopamine and serotonergic innervations.
Microdialysis study of the effects of the antiparkinsonian drug budipine on L‐DOPA‐induced release of dopamine and 5‐hydroxytryptamine by rat substantia nigra and corpus striatum
- Biology, ChemistrySynapse
- 1999
It is concluded that budipine, at a therapeutically relevant dose, potentiates the release of dopamine newly synthesised from L‐DOPA from either end of the nigrostriatal dopamine axis.
Biochemical effects of the monoamine neurotoxins DSP‐4 and MDMA in specific brain regions of MAO‐B‐deficient mice
- Biology, ChemistrySynapse
- 2001
The present findings suggest that MAO‐B is not involved in the mechanism of action of DSP‐4, whereas it plays opposite roles in MDMA‐induced DA and 5HT depletions.
Striatal Dopamine Metabolism in Monoamine Oxidase B‐Deficient Mice : A Brain Dialysis Study
- Biology, ChemistryJournal of neurochemistry
- 1999
It is suggested that in mice, DA is only metabolized byMAO A under basal conditions and by both MAO A and B at high concentrations, in contrast to the rat, where DA is always metabolizing by MAO B regardless of concentration.
Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway
- Biology, ChemistryNeuropharmacology
- 2013
Effects of Catechol-O-methyltransferase Inhibition on the Rates of Uptake and Reversibility of 6-Fluoro-l-Dopa Trapping in MPTP-induced Parkinsonism in Monkeys
- Biology, MedicineNeuropharmacology
- 1997
Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey.
- Biology, ChemistryJournal of neural transmission. Supplementum
- 1998
Striatal extracellular fluid concentrations of dopamine and metabolites in response to direct striatal administration of two L-DOPA boluses administered sequentially were determined in three rhesus…
The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats
- Biology, ChemistryJournal of Neural Transmission
- 2000
The results suggest that PF9601N may be used as a novel tool in the treatment of Parkinson's disease by enhancing the duration of contralateral rotational behavior with respect to L-DOPA plus vehicle in a dose-related manner.
Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
- Biology, ChemistryEuropean journal of pharmacology
- 2001
References
SHOWING 1-10 OF 55 REFERENCES
l‐3,4‐Dihydroxyphenylalanine‐Induced Dopamine Release in the Striatum of Intact and 6‐Hydroxydopamine‐Treated Rats: Differential Effects of Monoamine Oxidase A and B Inhibitors
- Biology, ChemistryJournal of neurochemistry
- 1994
A model in which exogenous l‐DOPA elicits enhanced extracellular accumulation of dopamine in the dopamine‐depleted striatum is supported because some transmitter synthesis occurs at nondopaminergic sites and the dopamine terminals that normally take up and catabolize this pool of transmitter are absent.
Brain Dialysis: In Vivo Metabolism of Dopamine and Serotonin by Monoamine Oxidase A but Not B in the Striatum of Unrestrained Rats
- Biology, ChemistryJournal of neurochemistry
- 1986
DA and 5‐HT in rat striatum may be preferentially deaminated by MAO‐A in vivo, and high‐dose treatment with clorgyline caused a significant decrease in levels of these three metabolites in both the perfusates and tissue homogenates.
Effects of Selective Monoamine Oxidase Inhibitors on the In Vivo Release and Metabolism of Dopamine in the Rat Striatum
- Biology, ChemistryJournal of neurochemistry
- 1990
Brain microdialysis was used to examine the in vivo efflux and metabolism of dopamine (DA) in the rat striatum following monoamine oxidase (MAO) inhibition, and data suggest that DA metabolism is mediated principally by MAO‐A in theRat striatum.
Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions
- Biology, ChemistryJournal of neural transmission. Parkinson's disease and dementia section
- 1990
The results suggest that the striatum with a reduction in DA nerve terminals is deficient both in the capacity to synthesize DA and in the storage mechanisms necessary to protect the newly synthesized DA from oxidative metabolism.
Dopamine metabolism in the guinea pig striatum: role of monoamine oxidase A and B.
- Biology, ChemistryEuropean journal of pharmacology
- 1994
Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats
- Biology, ChemistryBrain Research
- 1990
Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
- Biology, ChemistryThe Journal of pharmacology and experimental therapeutics
- 1991
In electrophysiological studies, single caudate neuron responses to iontophoretically applied (-)-apomorphine and (+/-)-2-(N-phenethyl-N-propyl) amino-5-hydroxytetralin were potentiated by intracarotid injections of PE and i.p. injections of (-)-deprenyl.
Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
- Biology, ChemistryJournal of neural transmission. Supplementum
- 1990
Reversible MAO-A inhibitors markedly increased the output of DA and concomitantly decreased theoutput of DOPAC and HVA, and these effects were absent with the highly selectiveMAO-B inhibitor Ro 19-6327.
Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.
- Chemistry, BiologyLife sciences
- 1985
The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
- Biology, ChemistryThe Journal of pharmacology and experimental therapeutics
- 1980
The nigrostriatal dopaminergic pathway was selected as a model system to determine the form (i.e., type A or B) of monoamine oxidase (MAO) present within central dopamine (DA)-containing neurons of the rat brain, and results strongly indicate the presence of the type A form of MAO.